(Q40045931)

16 September 2017

title

In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemopreventive agent (English)

1 reference

16 September 2017

Elena Maksimova

1

1 reference

16 September 2017

Ting-An Yie

series ordinal

2

1 reference

16 September 2017

William N Rom

series ordinal

3

1 reference

16 September 2017

publication date

22 November 2007

1 reference

16 September 2017

1 reference

16 September 2017

volume

186

1 reference

16 September 2017

issue

1

1 reference

16 September 2017

page(s)

45-54

1 reference

https://scigraph.springernature.com/pub.10.1007/s00408-007-9053-7

16 September 2017

exact match

0 references

cites work

Molecular and genetic aspects of lung cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00408-007-9053-7

Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorders.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00408-007-9053-7

Lovastatin induces apoptosis in malignant mesothelioma cells.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00408-007-9053-7

Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin

21 January 2018

1 reference

12 December 2020

Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin

1 reference

12 December 2020

Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone

1 reference

12 December 2020

Mevastatin-induced apoptosis and growth suppression in U266 myeloma cells.

1 reference

12 December 2020

Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells

1 reference

12 December 2020

Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans

1 reference

12 December 2020

Normal alveolar epithelial lining fluid contains high levels of glutathione

1 reference

12 December 2020

Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis

1 reference

12 December 2020

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study

1 reference

12 December 2020

Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells

1 reference

12 December 2020

Rho GTPases and signaling networks

1 reference

12 December 2020

Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling

1 reference

12 December 2020

Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor

1 reference

12 December 2020

Induction of apoptosis by lovastatin through activation of caspase-3 and DNase II in leukaemia HL-60 cells

1 reference

12 December 2020

Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism

1 reference

12 December 2020

Abrogation of insulin-like growth factor-I (IGF-I) and insulin action by mevalonic acid depletion: synergy between protein prenylation and receptor glycosylation pathways.

1 reference

12 December 2020

Lovastatin inhibits platelet-derived growth factor (PDGF) stimulation of phosphatidylinositol 3-kinase activity as well as association of p85 subunit to tyrosine-phosphorylated PDGF receptor

1 reference

12 December 2020

Enhanced sensitivity of G1 arrested human cancer cells suggests a novel therapeutic strategy using a combination of simvastatin and TRAIL.

1 reference

12 December 2020

Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death

1 reference

12 December 2020

Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models

1 reference

12 December 2020

Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.

1 reference

12 December 2020

MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling

1 reference

12 December 2020

Lovastatin 5-year safety and efficacy study. Lovastatin Study Groups I through IV

1 reference

12 December 2020

Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study

1 reference

12 December 2020

Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.

1 reference

12 December 2020

Apoptotic pathways and therapy resistance in human malignancies

1 reference

12 December 2020

3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation

1 reference

12 December 2020

Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin

1 reference

12 December 2020

The statins as anticancer agents

1 reference

12 December 2020

Pathways of apoptotic and non-apoptotic death in tumour cells

1 reference

12 December 2020

Increasing complexity of the Ras signaling pathway

1 reference

12 December 2020

Statins and cancer risk: a meta-analysis

1 reference

12 December 2020

Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase

1 reference

12 December 2020

10.1007/S00408-007-9053-7

Identifiers

DOI

1 reference

16 September 2017

1 reference